Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|May 23, 2007

Wyeth CFO and VC to Leave the Company

Kenneth J. Martin, Wyeth's (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June.

Kenneth J. Martin, Wyeth’s (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June. Martin joined the Wyeth in 1984 and has served as the CFO since 2000. The company plans to name a new CFO in advance of Martin’s departure.


Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.